1
|
Thompson EW, Newgreen DF and Tarin D:
Carcinoma invasion and metastasis: A role for
epithelial-mesenchymal transition? Cancer Res. 65:5991–5995;
discussion 5995. 2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Eccles SA and Welch DR: Metastasis: Recent
discoveries and novel treatment strategies. Lancet. 369:1742–1757.
2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
5
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
6
|
Chui MH: Insights into cancer metastasis
from a clinicopathologic perspective: Epithelial-mesenchymal
transition is not a necessary step. Int J Cancer. 132:1487–1495.
2013. View Article : Google Scholar
|
7
|
Nieto MA: Epithelial plasticity: A common
theme in embryonic and cancer cells. Science. 342:12348502013.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Nieto MA: The snail superfamily of
zinc-finger transcription factors. Nat Rev Mol Cell Biol.
3:155–166. 2002. View
Article : Google Scholar : PubMed/NCBI
|
9
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
12
|
Lamouille S, Subramanyam D, Blelloch R and
Derynck R: Regulation of epithelial-mesenchymal and
mesenchymal-epithelial transitions by microRNAs. Curr Opin Cell
Biol. 25:200–207. 2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Busch EL, McGraw KA and Sandler RS: The
potential for markers of epithelial-mesenchymal transition to
improve colorectal cancer outcomes: A systematic review. Cancer
Epidemiol Biomarkers Prev. 23:1164–1175. 2014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Bates RC and Mercurio AM: The
epithelial-mesenchymal transition (EMT) and colorectal cancer
progression. Cancer Biol Ther. 4:365–370. 2005. View Article : Google Scholar : PubMed/NCBI
|
16
|
Nowell PC: The clonal evolution of tumor
cell populations. Science. 194:23–28. 1976. View Article : Google Scholar : PubMed/NCBI
|
17
|
Yachida S, Jones S, Bozic I, Antal T,
Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, et al:
Distant metastasis occurs late during the genetic evolution of
pancreatic cancer. Nature. 467:1114–1117. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Gerlinger M, Rowan AJ, Horswell S, Larkin
J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A,
Tarpey P, et al: Intratumor heterogeneity and branched evolution
revealed by multiregion sequencing. N Engl J Med. 366:883–892.
2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Gerlinger M, Horswell S, Larkin J, Rowan
AJ, Salm MP, Varela I, Fisher R, McGranahan N, Matthews N, Santos
CR, et al: Genomic architecture and evolution of clear cell renal
cell carcinomas defined by multiregion sequencing. Nat Genet.
46:225–233. 2014. View
Article : Google Scholar : PubMed/NCBI
|
20
|
McGranahan N and Swanton C: Biological and
therapeutic impact of intratumor heterogeneity in cancer evolution.
Cancer Cell. 27:15–26. 2015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Schroeder A, Mueller O, Stocker S,
Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M
and Ragg T: The RIN: An RNA integrity number for assigning
integrity values to RNA measurements. BMC Mol Biol. 7:32006.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Saeed AI, Sharov V, White J, Li J, Liang
W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, et
al: TM4: A free, open-source system for microarray data management
and analysis. Biotechniques. 34:374–378. 2003.PubMed/NCBI
|
23
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar
|
24
|
Yang AD, Camp ER, Fan F, Shen L, Gray MJ,
Liu W, Somcio R, Bauer TW, Wu Y, Hicklin DJ, et al: Vascular
endothelial growth factor receptor-1 activation mediates epithelial
to mesenchymal transition in human pancreatic carcinoma cells.
Cancer Res. 66:46–51. 2006. View Article : Google Scholar : PubMed/NCBI
|
25
|
Zhou BP, Deng J, Xia W, Xu J, Li YM,
Gunduz M and Hung MC: Dual regulation of Snail by
GSK-3beta-mediated phosphorylation in control of
epithelial-mesenchymal transition. Nat Cell Biol. 6:931–940. 2004.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Brabletz T, Jung A, Reu S, Porzner M,
Hlubek F, Kunz-Schughart LA, Knuechel R and Kirchner T: Variable
beta-catenin expression in colorectal cancers indicates tumor
progression driven by the tumor environment. Proc Natl Acad Sci
USA. 98:10356–10361. 2001. View Article : Google Scholar : PubMed/NCBI
|
27
|
Spaderna S, Schmalhofer O, Hlubek F, Berx
G, Eger A, Merkel S, Jung A, Kirchner T and Brabletz T: A
transient, EMT-linked loss of basement membranes indicates
metastasis and poor survival in colorectal cancer.
Gastroenterology. 131:830–840. 2006. View Article : Google Scholar : PubMed/NCBI
|
28
|
Peña C, García JM, Silva J, García V,
Rodríguez R, Alonso I, Millán I, Salas C, de Herreros AG, Muñoz A,
et al: E-cadherin and vitamin D receptor regulation by SNAIL and
ZEB1 in colon cancer: Clinicopathological correlations. Hum Mol
Genet. 14:3361–3370. 2005. View Article : Google Scholar : PubMed/NCBI
|
29
|
Pasquinelli AE: MicroRNAs and their
targets: Recognition, regulation and an emerging reciprocal
relationship. Nat Rev Genet. 13:271–282. 2012.PubMed/NCBI
|
30
|
Peiró-Chova L, Peña-Chilet M,
López-Guerrero JA, García-Giménez JL, Alonso-Yuste E, Burgues O,
Lluch A, Ferrer-Lozano J and Ribas G: High stability of microRNAs
in tissue samples of compromised quality. Virchows Arch.
463:765–774. 2013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Wellner U, Schubert J, Burk UC,
Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D,
zur Hausen A, et al: The EMT-activator ZEB1 promotes tumorigenicity
by repressing stemness-inhibiting microRNAs. Nat Cell Biol.
11:1487–1495. 2009. View
Article : Google Scholar : PubMed/NCBI
|
32
|
Uhlmann S, Zhang JD, Schwäger A,
Mannsperger H, Riazalhosseini Y, Burmester S, Ward A, Korf U,
Wiemann S and Sahin O: miR-200bc/429 cluster targets PLCgamma1 and
differentially regulates proliferation and EGF-driven invasion than
miR-200a/141 in breast cancer. Oncogene. 29:4297–4306. 2010.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Toiyama Y, Hur K, Tanaka K, Inoue Y,
Kusunoki M, Boland CR and Goel A: Serum miR-200c is a novel
prognostic and metastasis-predictive biomarker in patients with
colorectal cancer. Ann Surg. 259:735–743. 2014. View Article : Google Scholar :
|